Skip to content
PubMed This is a summary of 9 peer-reviewed journal articles Updated
Rheumatology

Missed a SAPHO Biologic Dose? What Should You Do Next?

At a Glance

After missing a biologic dose for SAPHO syndrome, do not take extra medication or change the schedule yourself. Contact your rheumatology team, pharmacist, or infusion center with the drug and delay details, especially if you are ill or taking antibiotics.

If you miss a dose of your biologic (an immune-targeting medicine given by injection or infusion) for SAPHO syndrome, do not take a double dose to make up for it. A missed dose can be stressful, and it is reasonable to ask your clinic for a written missed-dose plan in advance, but if you do not have one, contact your prescribing rheumatology team, pharmacist, or infusion center for specific instructions. The correct steps will depend on exactly which medicine you use, how late the dose is, and the reason for the delay.

Why You Need Specific Instructions

SAPHO syndrome is rare, and treatments are highly individualized [1][2]. There is no single “grace period” or universal rule for a missed dose. Your care team will tell you what to do based on:

  • Which medication you take: Different biologics stay in your body for different lengths of time. If you use self-injections, the instructions for resetting your schedule will come from the medication’s specific guidelines. If you receive infusions, you will need to coordinate directly with the infusion center.
  • The reason for the delay: Delays due to travel, scheduling, or insurance require setting up a new timeline. If you missed a dose because of an active infection or illness, your doctor may need to evaluate you first [3].

Managing Illness and Antibiotics

If you are sick or taking antibiotics, do not automatically stop your biologic unless your doctor tells you to, and continue taking your antibiotics as prescribed. Taking an antibiotic does not automatically mean you must skip a biologic dose—it depends on the severity of the infection and the specific biologic you are on.

  • Always call your rheumatology team to explain your symptoms and ask if you should hold or take your next dose.
  • Biologics like TNF inhibitors can increase the risk of serious bacterial, fungal, or viral infections [4]. It is generally recommended to pause some biologics, like TNF inhibitors, during an active infectious disease [3].

Monitoring Symptoms and Urgent Red Flags

During an interruption in treatment, your SAPHO symptoms might return [5]. However, because SAPHO-related bone inflammation can sometimes mimic an infection, it can be hard to tell the difference yourself [6]. Do not try to diagnose the cause on your own; report any concerning changes to your doctor. Your doctor may evaluate your symptoms clinically or use targeted imaging, such as an MRI scan of the painful area, to see if there is active disease [7][8].

Seek urgent medical care if you experience any of these red flags, which could indicate a severe infection rather than just a SAPHO flare:

  • Trouble breathing or new severe chest pain
  • Confusion, severe weakness, or fainting
  • High or persistent fever with shaking chills
  • Rapidly spreading redness, warmth, or drainage from a skin lesion

Special Warning for IL-17 Inhibitors: If your biologic is an IL-17 inhibitor, be aware that these medications are sometimes associated with bowel inflammation [9]. Seek urgent care for severe abdominal pain, persistent or bloody diarrhea, significant dehydration, or unintended weight loss [9].

Action Checklist for a Missed Dose

  1. Identify the details: Note the exact name of your medication, the dose, whether it is an injection or infusion, and the date you were supposed to take it.
  2. Do not double up: Never take an extra dose or independently change your schedule to catch up.
  3. Call your team: Contact your prescriber, specialty pharmacist, or infusion center. If it is after hours, look for an on-call number.
  4. Report symptoms: Tell them if you have a fever, are taking any antibiotics, or have worsening bone pain or rashes.
  5. Record the new plan: Write down exactly when you should take your next dose and how it affects your future schedule.

Common questions in this guide

What should I do if I miss my SAPHO biologic dose?
Do not take a double dose or change your schedule on your own. Contact your rheumatology team, specialty pharmacist, or infusion center and provide the medication name, dose, route, scheduled date, and how late the dose is so they can give you a specific plan.
Should I skip my biologic if I have an infection or take antibiotics?
Do not automatically stop or take your biologic without medical advice. Call your rheumatology team, describe your illness, and follow their instructions because the decision depends on the infection and the specific medicine. Continue antibiotics exactly as prescribed.
Is there a standard grace period for a missed SAPHO biologic dose?
No. The correct timing depends on the biologic, whether it is an injection or infusion, how late the dose is, and why it was delayed. Your prescribing team or infusion center should tell you when to take the next dose and whether your usual schedule changes.
Can missing a biologic dose make SAPHO symptoms come back?
An interruption in treatment may allow symptoms such as bone pain or skin changes to return. SAPHO inflammation can sometimes resemble an infection, so report new or worsening symptoms to your doctor rather than trying to determine the cause yourself.
When should I seek urgent care after missing a biologic dose?
Seek urgent care for trouble breathing, new severe chest pain, confusion, fainting, severe weakness, or a high or persistent fever with shaking chills. Rapidly spreading redness, warmth, or drainage from a skin lesion also needs prompt evaluation. If you use an IL-17 inhibitor, seek urgent care for severe abdominal pain, persistent or bloody diarrhea, dehydration, or unexplained weight loss.

Get notified when new evidence is published on SAPHO syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (9)
  1. 1

    Treatment and monitoring of SAPHO syndrome: a systematic review.

    Li SWS, Roberts E, Hedrich C

    RMD open 2023; (9(4)) doi:10.1136/rmdopen-2023-003688.

    PMID: 38151265
  2. 2

    SAPHO syndrome: a review.

    Rukavina I

    Journal of children's orthopaedics 2015; (9(1)):19-27 doi:10.1007/s11832-014-0627-7.

    PMID: 25585872
  3. 3

    Fungal infections following treatment with monoclonal antibodies and other immunomodulatory therapies.

    Candel FJ, Peñuelas M, Tabares C, et al.

    Revista iberoamericana de micologia 2020; (37(1)):5-16 doi:10.1016/j.riam.2019.09.001.

    PMID: 31843275
  4. 4

    ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Soluble immune effector molecules [I]: anti-tumor necrosis factor-α agents).

    Baddley JW, Cantini F, Goletti D, et al.

    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2018; (24 Suppl 2()):S10-S20 doi:10.1016/j.cmi.2017.12.025.

    PMID: 29459143
  5. 5

    Dramatic response of synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome to tofacitinib monotherapy: a case report.

    Dierckx S, Nisolle JF, Boutsen Y

    Journal of medical case reports 2024; (18(1)):57 doi:10.1186/s13256-024-04366-w.

    PMID: 38360816
  6. 6

    Synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome presenting with a cervical vertebral fracture: A case report.

    Nedley A, Ramos O, Zuppan C, et al.

    North American Spine Society journal 2021; (5()):100050 doi:10.1016/j.xnsj.2021.100050.

    PMID: 35141616
  7. 7

    [Diagnosis and treatment of chronic nonbacterial osteitis (CNO) and SAPHO syndrome : Implications of the current consensus recommendations of an international commission of experts for German rheumatology].

    Assmann G, Klemm PCM, Hedrich C, et al.

    Zeitschrift fur Rheumatologie 2026; (85(2)):93-105 doi:10.1007/s00393-025-01741-w.

    PMID: 41313366
  8. 8

    Tofacitinib in chronic non-bacterial osteitis: a potential therapeutic option for multifocal osteitis.

    Kale V, Yadav S, Canchi B

    Journal of rheumatic diseases 2026; (33(4)):315-319 doi:10.4078/jrd.2025.0051.

    PMID: 42812283
  9. 9

    Colitis induced by IL-17A-inhibitors.

    Grümme L, Dombret S, Knösel T, et al.

    Clinical journal of gastroenterology 2024; (17(2)):263-270 doi:10.1007/s12328-023-01893-9.

    PMID: 38060157

This page is for informational purposes only and does not constitute medical advice. Contact your rheumatology team for instructions specific to your biologic, the timing of the missed dose, and your symptoms.